» Articles » PMID: 37046309

Movement Disorders Are Linked to TDP-43 Burden in the Substantia Nigra of FTLD-TDP Brain Donors

Overview
Publisher Biomed Central
Specialty Neurology
Date 2023 Apr 12
PMID 37046309
Authors
Affiliations
Soon will be listed here.
Abstract

Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson's disease and include bradykinesia, rigidity, and tremor. They are also present in frontotemporal dementia (FTD), where MD have been linked to frontotemporal lobar degeneration with tau pathology (FTLD-tau). Although MD can also occur in FTLD with TDP-43 pathology (FTLD-TDP), the local pathology in the SN of FTLD-TDP patients with MD is currently unexplored. The aims of this study are to characterize the frequency and the nature of MD in a cohort of FTLD-TDP brain donors and to investigate the relationship between the presence of MD, the nigral neuronal loss, and the TDP-43 burden in the SN. From our cohort of FTLD-TDP patients (n = 53), we included 13 donors who presented with MD (FTLD-MD+), and nine age-sex matched donors without MD (FTLD-MD-) for whom the SN was available. In these donors, the TDP-43 burden and the neuronal density in the SN were assessed with ImageJ and Qupath software. The results were compared between the two groups using T-test. We found that the TDP-43 burden in the SN was higher in FTLD-MD+ (mean 3,43%, SD ± 2,7) compared to FTLD-MD- (mean 1,21%, SD ± 0,67) (p = 0,04), while no significant difference in nigral neuronal density was found between the groups (p = 0,09). 17% of FTLD-TDP patients developed MD, which present as symmetric akinetic-rigid parkinsonism or CBS. Given the absence of a significant nigral neuronal cell loss, TDP-43 induced neuronal dysfunction could be sufficient to cause MD.

Citing Articles

Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data-driven clinicopathologic study.

Ono D, Sekiya H, Maier A, Murray M, Koga S, Dickson D Alzheimers Dement. 2025; 21(3):e14628.

PMID: 40042515 PMC: 11881629. DOI: 10.1002/alz.14628.


Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study.

Murakami A, Koga S, Fujioka S, White A, Bieniek K, Sekiya H Brain Pathol. 2024; 35(1):e13286.

PMID: 38988008 PMC: 11669411. DOI: 10.1111/bpa.13286.


The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.

Benatar M, Wuu J, Huey E, McMillan C, Petersen R, Postuma R Nat Rev Neurol. 2024; 20(6):364-376.

PMID: 38769202 PMC: 11216694. DOI: 10.1038/s41582-024-00961-z.


Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.

Leiby A, Scambray K, Nguyen H, Basith F, Fakhraee S, Melikyan Z J Alzheimers Dis. 2023; 96(1):113-124.

PMID: 37742640 PMC: 10615772. DOI: 10.3233/JAD-230238.

References
1.
Hoglinger G, Respondek G, Stamelou M, Kurz C, Josephs K, Lang A . Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017; 32(6):853-864. PMC: 5516529. DOI: 10.1002/mds.26987. View

2.
Park H, Chung S . New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord. 2014; 6(1):1-8. PMC: 4027647. DOI: 10.14802/jmd.13001. View

3.
Espay A, Litvan I . Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011; 45(3):343-9. PMC: 3324113. DOI: 10.1007/s12031-011-9632-1. View

4.
Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

5.
Hornykiewicz O . Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis. 2008; 5(3-4):114-7. DOI: 10.1159/000113678. View